K894370

Substantially Equivalent

GENESIS III, (MOD. 7003/7004)

Applicant: Biosound, Inc.
Product code: DXK
Advisory panel: Cardiovascular
Date received: 1989-07-14
Decision date: 1990-01-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.